Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Clinical trial NCT03772340 · COMPLETED
Trial details
- NCT number
- NCT03772340
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2019-06-06
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.